Loading...

GraniteShares 3x Long Moderna Daily ETC

3LMO.L•LSE
Financial Services
Asset Management - Leveraged
£41.48
£3.13(8.16%)

GraniteShares 3x Long Moderna Daily ETC (3LMO.L) Stock Overview

Explore GraniteShares 3x Long Moderna Daily ETC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 68.4/100

Key Financials

Market Cap1.6M
P/E RatioN/A
EPS (TTM)N/A
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Week$38.29
1 Month$18.81
3 Months$0.00
1 Year Target$0.01

3LMO.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GraniteShares 3x Long Moderna Daily ETC (3LMO.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 77.31, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 1.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

77.31RSI (14)
5.45MACD
45.43ADX
Stats data is not available for 3LMO.LStats details for 3LMO.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for 3LMO.LAnalyst Recommendations details for 3LMO.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

GraniteShares 3x Long Moderna Daily ETP is designed to enable investors to gain 3 time exposure to a total return investment in MRNA (the Underlying Stock).

Founded

2021

Frequently Asked Questions

;